Brought to you by:
Pulse IVL system US pivotal trial enrolls first patient
Amplitude Vascular Systems (AVS) recently announced that it has enrolled the first patient in its U.S. pivotal trial for pulsatile intravascular lithotripsy (IVL) therapy. A press release notes that the POWER PAD II clinical study will evaluate the safety and…
SVS remains nimble in face of spreading pandemic, pivots to member priorities
The Society for Vascular Surgery (SVS) started 2020 with plans intensifying for the Vascular Research Initiatives Conference (VRIC) in May, the Vascular Annual Meeting (VAM) in June, the launch of the branding initiative, along with a host of other SVS…